ZIP14 was reported to be upregulated in skeletal muscles of mice and patients with metastatic cancers, while ZIP14-mediated zinc uptake in muscle progenitor cells and differentiated myocytes repressed the expression of MyoD and MYH, respectively, promoting muscle wasting in cancer cachexia35. Here, SLC39A14 is linked to metastatic malignant neoplasm.